FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to an agent for mucociliary clearance improvement. The medicinal agent for mucociliary clearance improvement containing gamma-L-glutamyl histamine, fudosteine, leptin, growth transformation factor - β3, ectericide, glycerine, rotocan, yellow sweet clover blossom extract CK-CO2, dropwort blossom extract CK-CO2, origanum extract CK-CO2, taken in a certain ratio.
EFFECT: agent effectively improves mucociliary clearance, allows to improve considerably clinical effectiveness and to reduce treatment length in acute and chronic diseases, to prevent recurrence development and distribution of the pathological process.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING PLANT-BASED MEDICINE OF ANTI-INFLAMMATORY AND ANTIMICROBIAL ACTION | 2018 |
|
RU2676085C1 |
| OPHTHALMIC ANTI-INFLAMMATORY AGENT | 2009 |
|
RU2407528C1 |
| MEDICINAL AGENT FOR TOPICAL TREATMENT OF MUCOSA AND SKIN | 2001 |
|
RU2214818C2 |
| ANTIPHLOGISTIC, RESTORATIVE AND SPASMOLYTIC PREPARATION | 2001 |
|
RU2177796C1 |
| OFFICINAL TEA FOR TREATMENT OF PATIENTS SUFFERING FROM THROMBUS OCCLUSION INJURY OF HEAD AND NECK ARTERIES | 2006 |
|
RU2313359C1 |
| MEDICINE OF ANTIOXIDANT ACTION | 2006 |
|
RU2325179C1 |
| MEANS AND METHOD FOR CARRYING OUT CHRONOBIOLOGICAL CORRECTION | 2004 |
|
RU2317822C2 |
| AGENT FOR TREATMENT OF CHRONIC VIRAL HEPATITIS B | 2000 |
|
RU2180228C1 |
| PHYTAON-1,2: BIOLOGICALLY ACTIVE COMPOSITION AND METHOD FOR PREPARING SAME | 1995 |
|
RU2106875C1 |
| MASSAGE PREPARATIONS BY AGAPOV VA | 2008 |
|
RU2391965C2 |
